- Issuer ticker
-
AGL
- Reported as of
-
01 Apr 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
03 Apr 2025, 19:37:35 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Mimi Yang, as Attorney-in-Fact
Key filing fact
Timothy Gertsch filed Form 4 for agilon health, inc. (AGL) on 03 Apr 2025.
Key facts
- This page summarizes Timothy Gertsch's Form 4 filing for agilon health, inc. (AGL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2025, 19:37.
Change
- Previous filing in this sequence was filed on 20 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +61,275
- Change %
- +106%
- Price
-
$0.000000
- Shares after
- 119,035
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGL
transaction
Derivative
Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +96,154
- Change %
- Price
-
$0.000000
- Shares after
- 96,154
- Date
- 01 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 96,154
- Exercise price
- $4.08
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes